Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Double Blinded Randomized Placebo Controlled Multi Central Clinical Trial on Inflammatory Regulation Effect of NAC on COVID-19

NCT04455243 is registered in ClinicalTrials.gov with Dr. Tariq Alhawassi as lead sponsor.

NCT NCT04455243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04455243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Double Blinded Randomized Placebo Controlled Multi Central Clinical Trial on Inflammatory Regulation Effect of NAC on COVID-19
Lead sponsor
Dr. Tariq Alhawassi
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 30, 2021
Enrollment
1,180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19